Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 163,482 |
|
|||||
| News | - | ||||||
| Day High | 1.05 | Low High |
|||||
| Day Low | 0.9901 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Unicycive Therapeutics Inc | UNCY | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0448 | -4.31% | 0.9952 | 11:07:05 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.04 | 0.9901 | 1.05 | 1.04 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 285 | 163,482 | $ 1.01 | $ 164,576 | - | 0.47 - 1.8227 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:08:33 | 8 | $ 0.9952 | USD |
Unicycive Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 34.75M | 34.75M | - | 675k | -31.41M | -0.90 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Unicycive Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical UNCY Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.15 | 1.1999 | 0.9853 | 1.09 | 401,121 | -0.1548 | -13.46% |
| 1 Month | 1.46 | 1.60 | 0.9853 | 1.25 | 399,901 | -0.4648 | -31.84% |
| 3 Months | 0.95 | 1.818 | 0.91 | 1.37 | 390,263 | 0.0452 | 4.76% |
| 6 Months | 0.7696 | 1.818 | 0.47 | 1.17 | 272,891 | 0.2256 | 29.31% |
| 1 Year | 1.55 | 1.8227 | 0.47 | 1.20 | 198,615 | -0.5548 | -35.79% |
| 3 Years | 8.55 | 8.73 | 0.4004 | 1.96 | 738,101 | -7.55 | -88.36% |
| 5 Years | 8.55 | 8.73 | 0.4004 | 1.96 | 738,101 | -7.55 | -88.36% |
Unicycive Therapeutics Description
| Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. |
